Weight loss drugs linked to surprising benefits for migraines and asthma

Stay up to date with notifications from The IndependentNotifications can be managed in browser preferences.AllNewsSportCultureLifestyleNew research indicates that weight-loss medications, specifically GLP-1RA drugs, may alleviate migraine pain and reduce asthma symptoms. A study presented at the European Congress On Obesity found that women using Wegovy for weight management experienced a 7 per cent reduction in prescriptions for triptan-class migraine medication. Separately, another study revealed that individuals prescribed GLP-1 drugs for obesity or type 2 diabetes saw a 26 per cent fall in asthma exacerbations and a 14 per cent drop in reliever inhaler use. Experts suggest that the weight loss achieved with these medications is a significant factor, as it reduces the pro-inflammatory state linked to excess fatty tissue. These findings contribute to a growing body of evidence highlighting the potential therapeutic benefits of GLP-1RA drugs beyond their primary use for weight loss. In fullWeight loss drugs could ease migraine pain and reduce asthma symptoms, experts sayThank you for registeringPlease refresh the page or navigate to another page on the site to be automatically logged inPlease refresh your browser to be logged in

Raccontata damirror.co.ukindependent.co.uk